SCHEMBL1551769

SCHEMBL1551769

CCC(CCS)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2872460 0.86 CA2 (0.68)
SCHEMBL7205350 0.84 CA2 (0.65)
SCHEMBL2871925 0.84 FOLH1 (0.76)
SCHEMBL125406 0.84 CA2 (0.71)
SCHEMBL16062298 0.83 CHRM1 (0.76)
SCHEMBL2871927 0.83 CHRM1 (0.76)
SCHEMBL16061483 0.83 CHRM1 (0.76)
SCHEMBL5682109 0.82 FOLH1 (0.63)
SCHEMBL19713145 0.82 FOLH1 (0.63)
SCHEMBL19862678 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115746466-A High-impact-resistance polystyrene composite material and preparation process thereof 江苏绿安擎峰新材料有限公司 2023-03-07 CN claimed
EP-1570835-B1 Composition for the permanent deformation of the hair comprising at least one carboxydithiol OREAL (FR) 2010-10-20 EP claimed
US-20260000632-A1 STRUCTURALLY MODIFIED FATTY ACIDS FOR IMPROVING GLYCEMIC CONTROL AND TREATING INFLAMMATORY BOWEL DISEASE NORTHSEA THERAPEUTICS B V (NL) 2026-01-01 US disclosed
US-12465580-B2 Substituted fatty acids for treating non-alcoholic steatohepatitis BASF AS (NO) 2025-11-11 US disclosed
EP-3288550-B1 STRUCTURALLY ENHANCED FATTY ACIDS CONTAINING SULPHUR FOR THEIR USE IN TREATING NON-ALCOHOLIC STEATOHEPATITIS BASF AS (NO) 2024-06-05 EP disclosed
US-20240156760-A1 SUBSTITUTED FATTY ACIDS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS BASF AS (NO) 2024-05-16 US disclosed
US-11911354-B2 Substituted fatty acids for treating non-alcoholic steatohepatitis BASF (NO) 2024-02-27 US disclosed
CN-115746466-A High-impact-resistance polystyrene composite material and preparation process thereof 江苏绿安擎峰新材料有限公司 2023-03-07 CN disclosed
US-20220280459-A1 SUBSTITUTED FATTY ACIDS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS BASF AS (NO) 2022-09-08 US disclosed
US-11234948-B2 Substituted fatty acids for treating non-alcoholic steatohepatitis BASF AS (NO) 2022-02-01 US disclosed
US-20210290576-A1 STRUCTURALLY MODIFIED FATTY ACIDS FOR IMPROVING GLYCEMIC CONTROL AND TREATING INFLAMMATORY BOWEL DISEASE BASF AS (NO) 2021-09-23 US disclosed
WO-2016173923-A1 USE OF STRUCTURALLY ENHANCED FATTY ACIDS CONTAINING SULPHUR FOR PREVENTING AND/OR TREATING NON-ALCOHOLIC STEATOHEPATITIS PRONOVA BIOPHARMA NORGE AS (NO) 2016-11-03 WO disclosed
CN-105873999-A Rubber composition and pneumatic tire having tread fabricated using rubber composition 住友橡胶工业株式会社 2016-08-17 CN disclosed
EP-2313090-B1 NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT PRONOVA BIOPHARMA NORGE AS (NO) 2016-03-30 EP disclosed
US-20140316002-A1 NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT PRONOVA BIOPHARMA NORGE AS (NO) 2014-10-23 US disclosed
US-8759558-B2 Sulphur containing lipids for use as food supplement or as medicament PRONOVA BIOPHARMA NORGE AS (NO) 2014-06-24 US disclosed
US-20110190395-A1 NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT PRONOVA BIOPHARMA NORGE AS (NO) 2011-08-04 US disclosed
EP-2313090-A1 NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT Pronova BioPharma Norge AS (NO) 2011-04-27 EP disclosed
EP-1570835-B1 Composition for the permanent deformation of the hair comprising at least one carboxydithiol OREAL (FR) 2010-10-20 EP disclosed
WO-2010008299-A1 NOVEL SULPHUR CONTAINING LIPIDS FOR USE AS FOOD SUPPLEMENT OR AS MEDICAMENT PRONOVA BIOPHARMA NORGE AS (NO) 2010-01-21 WO disclosed